Can Medical Cannabis Affect Liver Enzymes?

Medical cannabis may affect liver enzymes in some patients, particularly when using high doses of cannabidiol (CBD) or combining cannabis products with certain medications. However, the risk varies based on the product, dose, existing liver health, and other medicines or supplements being used.

An elevated liver enzyme result does not automatically mean cannabis has caused permanent liver damage. It does mean the result should be discussed with a healthcare provider rather than ignored.

What Are Liver Enzymes?

Liver enzymes are proteins involved in important chemical processes throughout the body. Common enzymes measured during blood testing include:

• Alanine aminotransferase (ALT)
• Aspartate aminotransferase (AST)
• Alkaline phosphatase (ALP)
• Gamma-glutamyl transferase (GGT)

ALT and AST are often called liver enzymes, although AST is also found in muscles and other tissues. When liver cells become irritated or damaged, these enzymes may enter the bloodstream and appear elevated on laboratory testing.

High liver enzymes have many possible causes, including fatty liver disease, alcohol use, viral infections, medication side effects, supplements, strenuous exercise, and other medical conditions.

Can Medical Cannabis Raise ALT or AST?

SIt is possible, but the evidence is not the same for every cannabinoid or cannabis product.

Research has most clearly connected elevated liver enzymes with higher doses of oral CBD. The FDA-approved CBD medication Epidiolex carries a warning that it can cause dose-related elevations in ALT and AST. These elevations have occurred more frequently in patients taking certain anti-seizure medications, especially valproate. FDA prescribing information

A systematic review of clinical trials also found that CBD was associated with a greater likelihood of liver enzyme elevations than placebo. However, many studies evaluated concentrated CBD doses that may be considerably higher than those contained in some dispensary products. PubMed

Evidence that THC-dominant cannabis commonly causes significant liver injury is much weaker. According to the National Institutes of Health’s LiverTox database, marijuana has not been convincingly linked to routine liver enzyme elevations or clinically apparent liver injury with jaundice. Research involving different products, doses, and patterns of use remains limited. LiverTox

Why CBD May Affect the Liver

Orally consumed CBD is processed extensively by the liver. At higher doses, it may place additional stress on liver cells and affect the enzymes responsible for metabolizing other substances.

Several factors may increase the likelihood of abnormal liver tests:

• High daily doses of CBD
• Concentrated oral CBD oils or solutions
• Existing liver disease
• Elevated liver enzymes before starting CBD
• Alcohol consumption
• Use of multiple medications or supplements
• Medicines that can affect the liver
• Products with inaccurate labels or contaminants

The National Center for Complementary and Integrative Health notes that CBD has been associated with liver injury, abnormalities on liver-function tests, and drug interactions. NCCIH

Does the Method of Cannabis Use Matter?

Possibly. Oral products, including capsules, oils, beverages, and edibles, undergo significant processing by the liver before entering the bloodstream. This process is known as first-pass metabolism.

Inhaled cannabis reaches the bloodstream through the lungs and initially bypasses much of this first-pass processing. However, this does not mean inhalation is risk-free. Smoking or vaping carries separate respiratory and cardiovascular concerns.

The product’s CBD and THC content, dose, frequency of use, and overall formulation may be more important than the product category alone.

Medical Cannabis and Medication Interactions

Cannabinoids—especially CBD—may affect liver enzymes involved in breaking down prescription medications. This can change the amount of medication in the bloodstream, potentially increasing side effects or reducing effectiveness.

Possible interactions may occur with certain:

• Anti-seizure medications
• Blood thinners
• Sedatives
• Antidepressants
• Immunosuppressants
• Heart medications
• Medicines carrying their own liver warnings

The presence of a possible interaction does not always mean the combination is unsafe. It may mean that closer monitoring or dosage adjustments are needed. Patients should give their cannabis clinician, primary-care provider, pharmacist, and relevant specialists a complete list of medications and supplements.

Should Liver Enzymes Be Monitored?

Routine liver testing is not automatically required for every medical cannabis patient. A healthcare provider may recommend baseline or follow-up testing for patients who:

• Have liver disease or fatty liver disease
• Previously had elevated ALT or AST
• Use high-dose or concentrated CBD
• Take medications processed by the liver
• Take medicines known to affect liver function
• Consume alcohol regularly
• Develop symptoms that may suggest a liver problem

The appropriate testing schedule depends on the patient’s health, treatment plan, cannabinoid dose, and medications.

What Should You Do If Your Liver Enzymes Are Elevated?

Do not assume medical cannabis is the cause, and do not stop prescribed medications without medical guidance.

Your provider may review:

1. The exact cannabis products and doses you use
2. When you started or changed your cannabis treatment
3. Prescription and over-the-counter medications
4. Vitamins, herbs, and dietary supplements
5. Alcohol use
6. Previous laboratory results
7. Other possible causes of abnormal liver tests

Depending on the findings, the provider may repeat the blood test, adjust the cannabinoid dose, recommend a different formulation, review interacting medications, or investigate another medical cause.

Seek prompt medical attention for yellowing of the skin or eyes, dark urine, pale stools, severe abdominal pain, persistent vomiting, unusual itching, confusion, or extreme fatigue.

Can Patients With Liver Disease Use Medical Cannabis?

Having liver disease does not automatically rule out medical cannabis, but treatment should be approached cautiously and individually.

A lower starting dose, slower dose increases, careful product selection, and closer laboratory monitoring may be appropriate. Patients should avoid changing or adding concentrated CBD products without discussing them with a qualified healthcare provider.

Frequently Asked Questions

Does CBD raise liver enzymes?

High-dose oral CBD can raise ALT and AST in some patients. The likelihood may increase with higher doses, existing liver abnormalities, or certain interacting medications.

Does THC damage the liver?

Current evidence does not clearly establish THC-containing cannabis as a common cause of clinically apparent liver injury. However, research is incomplete, and individual factors still matter.

Will elevated liver enzymes return to normal?

They may return to normal after the underlying cause is addressed, but the outcome depends on what caused the elevation. Follow-up testing and medical evaluation are important.

Should I stop medical cannabis if my ALT or AST is high?

Do not make treatment changes based on one test without speaking with a healthcare provider. Abruptly stopping cannabis or another medicine may worsen symptoms or create additional risks.

Can edibles affect the liver more than inhaled cannabis?

Edibles undergo first-pass metabolism in the liver. However, liver risk depends on multiple factors, including CBD concentration, total dose, frequency of use, medications, and existing liver health.

Conclusion

Medical cannabis can affect liver enzymes, with the strongest evidence involving higher-dose oral CBD. THC-dominant cannabis has not been clearly linked to liver injury in the same way, but research remains limited.

Patients with liver disease, abnormal laboratory results, or medications that interact with cannabinoids should work closely with qualified healthcare professionals. A personalized treatment plan and appropriate monitoring can help reduce avoidable risks.

If you are considering medical cannabis or need to renew your certification, Compassionate Care Consultants can help you understand the evaluation process and discuss whether medical cannabis may be appropriate for your condition.

If you feel your medical cannabis isn’t working as well as it used to, don’t increase your dose on your own. Speak with a qualified medical marijuana provider to review your treatment plan and determine the best next steps.

If you haven’t yet obtained your mmj card, be sure to take a look at Compassionate Care Consultant full guide on how to get a medical marijuanas card in Pennsylvania. Ready to schedule a consultation and take the next steps to become a registered patient? Reach out to schedule an appointment.